SCHEMBL4554819

SCHEMBL4554819

COC(=O)C1C=CC=CC1=C=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butylamine SCHEMBL28050712 0.86 DNTT (0.36)
SCHEMBL27258058 0.84
SCHEMBL27491016 0.81 NFKB1 (0.33) ALDH1A1
Hydrazine SCHEMBL28030851 0.79 NFKB1 (0.32) ALDH1A1
SCHEMBL28843521 0.79 ALDH1A1 (0.33) ALDH1A1
SCHEMBL239044 0.77
SCHEMBL9868040 0.77
Hydrochloric Acid SCHEMBL5751359 0.76
SCHEMBL7929530 0.76 DNTT (0.37) ALDH1A1
Water SCHEMBL27822730 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101558049-B Substituted pyrazole and triazole compounds as KSP inhibitors NOVARTIS AG 2012-08-15 CN disclosed
CN-101175724-B pyrrolidine derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2011-12-07 CN disclosed
CN-101558049-A Substituted pyrazole and triazole compounds as KSP inhibitors NOVARTIS AG (CH) 2009-10-14 CN disclosed
EP-2013211-A2 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS Novartis AG (CH) 2009-01-14 EP disclosed
CN-101175724-A Pyrrolidine derivative or salt thereof ASTELLAS PHARMA INC (JP) 2008-05-07 CN disclosed
WO-2007121920-A2 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2007-11-01 WO disclosed